A detailed history of Covestor LTD transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Covestor LTD holds 1,233 shares of SMMT stock, worth $23,020. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,233
Previous 43 2767.44%
Holding current value
$23,020
Previous $0 Infinity%
% of portfolio
0.02%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$6.89 - $31.93 $8,199 - $37,996
1,190 Added 2767.44%
1,233 $27,000
Q1 2024

May 10, 2024

SELL
$2.55 - $5.07 $53 - $106
-21 Reduced 32.81%
43 $0
Q4 2023

Feb 09, 2024

SELL
$1.67 - $2.83 $11 - $19
-7 Reduced 9.86%
64 $0
Q3 2023

Nov 13, 2023

BUY
$1.54 - $2.42 $109 - $171
71 New
71 $0

Others Institutions Holding SMMT

About Summit Therapeutics Inc.


  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.76B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.